New and emerging theories of cardiovascular disease: Infection and elevated iron

Biological Research for Nursing

Volumn 6, Issue 1, 2004, Pages 3-10

  Alpert, Patricia T ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

C reactive proteins; Cardiac disease; Cardiovascular disease; Heart disease; Infection; Iron levels

Indexed keywords

ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; FERRITIN; FREE RADICAL;

BACTERIAL INFECTION; BLOOD; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHLAMYDOPHILA PNEUMONIAE; DEVELOPING COUNTRY; FEMALE; HUMAN; INFLAMMATION; IRON OVERLOAD; LIPID PEROXIDATION; MALE; METABOLISM; PHLEBOTOMY; PRIMARY PREVENTION; REVIEW; RISK FACTOR;

ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DEVELOPING COUNTRIES; FEMALE; FERRITINS; FREE RADICALS; HUMANS; INFLAMMATION; IRON OVERLOAD; LIPID PEROXIDATION; MALE; PHLEBOTOMY; PRIMARY PREVENTION; RISK FACTORS;

EID: 3843097333     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800404264777     Document Type: Article

References (55)

1. Anderson JL, Muhlestein JB, Carlquist J, Allen A, Trehan S, Nielson C, Hall S, Brady J, Egger M, Horne B, and others. 1999. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. Circulation 99:1540-7.
2. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. 2001. Blood donations and risk of coronary heart disease in men. Circulation 103:52-7.
3. Baer DM, Tekawa IS, Hurley LB. 1994. Iron stores are not associated with acute myocardial infarction. Circulation 89:2915-8.
4. Benditt EP, Barrett T, McDougall JK. 1983. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci U S A 80:6386-9.
5. Boman J, Soderberg S, Forsberg J. 1998. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 178:274-7.
6. Burt MJ, Hallyday JW, Powell LW. 1993. Iron and coronary heart disease, iron's role is undecided. BMJ 307:575-6.
7. Centers for Disease Control and Prevention. 13 November 2002. Facts about cardiovascular disease. Available at: http://www.cdc.gov/od/oc/media/fact/ cardiova.
8. Clark LT. 1992. Atherogenesis and thrombosis: mechanisms, pathogenesis, and therapeutic implications. Am Heart J 123:1106-9.
9. Cook PL, Lip GY, Davies P, Beevers DG, Wise R. 1998. Chlamydia pneumoniae antibodies in severe essential hypertension. Hypertension 31:589-94.
10. Davies KAJ, Quintanilha TA, Brooks GA. 1982. Free radical and tissue damage produced by exercise. Biochem Biophysiol Res Com 107:1198-205.
11. Ellis RW. 1996. Infection and coronary heart disease. J Micro 46:535-9.
12. Fernandez-Ortiz A, Fuster V. 1996. Pathophysiology of coronary artery disease. Clin Geriatr Med 12:1-20.
13. Gibbs RGJ, Carey N, Davies AH. 1998. Chlamydia pneumoniae and vascular disease. Br J Surg 85:1191-7.
14. Goldfarb AH, McIntah MK, Boyer BT, Fatouros J. 1994. Vitamin E effects on indexes of lipid peroxidation in muscle from DHEA-treated and exercised rats. J Appl Physiol 60:1630-5.
15. Grayston JT. 1996. Chlamydia pneumoniae and atherosclerosis. Rev Med Interne 17 Suppl 1:45S-7.
16. Gupta S, Camm J. 1997. Chronic infection in the etiology of atherosclerosis - the case for Chlamydia pneumoniae. Clin Cardiol 20:829-36.
17. Gupta S, Camm AJ. 1998. Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: a critical overview. Coron Artery Dis 9:339-43.
18. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. 1997. Randomized trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 350:404-7.
19. Gutteridge JMC, Halliwell B. 1989. Iron toxicity and oxygen radicals. Baillieres Clin Haematol 2:195-256.
20. Hahn DL, Golubjatnikov R. 1992. Smoking is a potential confounder of the Chlamydia pneumoniae coronary artery disease association. Arterioscler Thromb 12:255-60.
21. Jacob RA, Burri BJ. 1996. Oxidative damage and defense. Am J Clin Nutr 63:985S-90S.
22. Jenkins RR. 1988. Free radical chemistry: relationship to exercise. Sports Med 5:156-70.
23. Jenkins RR, Krause K, Schofield LS. 1993. Influence of exercise on clearance of oxidant stress products and loosely bound iron. Med Sci Sports Exerc 25:213-7.
24. Ji LL, Katz A, Fu R, Griffitys M, Spencer M. 1993. Blood glutathione status during exercise: effect of carbohydrate supplementation. J Appl Physiol 74:788-92.
25. Kalayoglu MU, Byrne GL. 1998. Induction of macrophage foam cell formation by Chlamydia pneumoniae - coronary artery disease association. Arterioscler Thromb 177:725-9.
26. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. 1997. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 96:3300-7.
27. Kumar H. 1994. Repeated blood donation effective in treating hyperlipidemia. J Assoc Physiol India 42:468-9.
28. Kuo CC, Campbell LA. 1998. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? Mol Med Today 4:426-30.
29. Kuo CC, Shor A, Campbell LA. 1993. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167:841-9.
30. Lauffer RB. 1990. Iron stores and the international variation in mortality from coronary artery disease. Med Hypotheses 35:96-102.
31. Lautrilla A, Bloigu A, Naya S, Hassi J, Leinonen M, Saikku P. 1997. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb 17:2910-3.
32. Maass M, Bartels C, Engel PM. 1998. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 31:827-32.
33. McCord JM. 1991. Is iron deficiency a risk factor in ischemic heart disease? Circulation 89:1112-3.
34. Meyers DG, Jensen Kc, Menitove JF. 2002. A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion 42:1135-9.
35. Meyers DG, Strickland D, Maloley PA, Seburg JJ, Wilson JE, McManus BF. 1997. Possible association of a reduction in cardiovascular events with blood donation. Heart 78:188-93.
36. Morrison HI, Semeneiw RM, Mao Y, Wigle DT. 1994. Serum iron and risk of fatal acute myocardial infarction. Epidemiology 5:243-6.
37. Muhlestein JB. 1998. Bacterial infections and atherosclerosis. J Invest Med 46:396-402.
38. Neumann FJ. 2002. Chlamydia pneumonia-atherosclerosis link: a sound concept in search for clinical relevance. Circulation 106:2414-6.
39. Neyens E, Baeyens J. 2003. A review of classic Fenton's peroxidation as an advanced oxidation technique. J Hazard Mater 98:33-50.
40. Nyyssonen K, Salonen R, Korpela H, Salonen JT. 1994. Elevation of serum high density lipoprotein cholesterol concentration due to lowering of body iron stores by blood letting. Eur J Lab Med 2:113-5.
41. Orfila JJ. 1998. Seroepidemiological evidence for an association between Chlamydia pneumoniae and atherosclerosis. Atherosclerosis 140 Suppl 1:S11-5.
42. Pai J, Knoop FC, Hunter WJ, Agrawal DK. 1998. Chlamydia pneumoniae and occlusive vascular disease: identification and characterization. J Pharmacol Toxicol Methods 39:51-61.
43. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. 2002. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 14(347):1557-65.
44. Saikku P, Leinonen M, Marttila K. 1998. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infection. Lancet 2:983-6.
45. Salonen JT. 1993. The role of iron as a cardiovascular risk factor. Curr Opin Lipidol 4:277-82.
46. Salonen JT, Nyyssonen K, Korpela H, Tuemilehto J, Seppanen R, Salonen R. 1992. High stored iron levels are associated with excessive risk of myocardial infarction in Eastern Finnish men. Circulation 86:803-11.
47. Sempos CT, Looker AC, Gillum RF. 1996. Iron and heart disease: the epidemiologic data. Nutr Rev 54:73-84.
48. Shor A, Kuo CC, Patton DL. 1992. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 82:158-61.
49. Spodick DH, Flessas AP, Johnson MM. 1984. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 53:481-2.
50. Sullivan JL. 1989. The iron paradigm of ischemic heart disease. Am Heart J 177:1177-88.
51. Taylor-Robinson D. 1998. Chlamydia pneumoniae in vascular tissue. Atherosclerosis 140 Suppl 1:S21-4.
52. Taylor-Robinson D, Thomas BJ. 1998. Chlamydia pneumoniae in arteries: the facts, their interpretation and future studies. J Clin Path 51:793-7.
53. Tuomainen TP, Salonen R, Myyssonen K, Salonen JT. 1997. Cohort study of relation between donating blood risk of myocardial infarction in 2,682 men in Eastern Finland. BMJ 314:793-4.
54. Wong Y, Dawkins K, Ward ME. 1998. Detection of C. pneumoniae DNA circulating in the blood of patients attending for cardiac angiography: preliminary clinical and serological correlates. In: Stephens RS, editor. Chlamydial infections, International Chlamydia Symposium. San Francisco. p 227-30.
55. Zahn R, Schneider S, Frilling B, Seidl K, Tebbe U, Weber M, Gottwik M, Altmann E, Seidel F, Rox J, and others, Working Group of Leading Hospital Cardiologists. 2003. Antibiotic therapy after acute myocardial infarction: a prospective randomized study. Circulation 107:1253-9.